2023 agenda

Friday May 12, 2023

7:00 – 8:00 Breakfast
8:00 – 8:05 Welcome to CMHCC Dr. Brandon Meyers
8:05 – 10:00 Early Stage Disease Chair: Dr. Chaya Shwaartz
8:10 – 8:50 Session
8:50 – 9:00 Question and Answer Period with Audience
9:00 – 9:35 Session
9:35 – 9:45 Question and Answer Period with the Audience
9:45 – 10:30 Early Stage Disease Panel Discussion/Cases with Audience Chair: Dr. Shwaartz, Panel: Med Onc, Rad Onc, Surgeon
10:05 – 10:30 Refreshment Break
10:30 – 12:00 Intermediate/Locally Advanced Stage Disease Chair: Dr. Laura Dawson
10:30 – 10:35 Welcome and Introductions ( Pre Debate Vote) Dr. Laura Dawson
10:35 – 11:10 Debate: Y90 vs External Beam RT Dr. Laura Dawson and Dr. David Liu
10:35 – 10:45 Y 90 Dr. David Liu
10:45 – 10:55 External Beam RT Dr. Laura Dawson
10:55 – 11:05 Rebuttals Dr. Laura Dawson and Dr. Dave Liu
11:05 – 11:10 Voting/ Discussion with Audience
11:10 – 11:45 Case Based Panel Discussion with Audience Chair: Dr. Laura Dawson, Panel: Dr. David Liu, Surgeon
11:45 – 13:00 Lunch
13:00 – 16:00 Afternoon Sessions Dr. Vincent Tam
13:05 – 13:50 Keynote: Advents in the Treatment of Hepatocellular Carcinoma. Where Are We Going? Dr. Abou Alfa
13:50 – 14:05 Question and Answer Period Dr. Abou Alfa
14:05 – 14:25 Refreshment Break
14:25 – 16:10 Advanced Stage DiseaseĀ  Chair: Dr. Rachel Goodwin
14:25 – 14:45 Trial Review Dr. Ravi Ramjeesingh
14:45 – 14:50 Question and Answer Period with the Audience Dr. Ravi Ramjeesingh
14:50 – 15:20 Debate:
Best 1st Line Therapy: Atezolizumab vs STRIDE
Dr. Vincent Tam &
Dr. Brandon Meyers
15:20 – 15:40 Voting and Question Period with the Audience
15:40 – 16:10 Advanced Stage Panel Discussion with Audience Chair: Dr. Rachel Goodwin, Panel: Dr. Brandon Myers, Dr. Vincent Tam, Rad Onc, Surgeon
16:10 – 16:15 Closing Remarks Dr. Vincent Tam